Advisory Services Network’s Immunovant IMVT Stock Holding History

Advisory Services Network’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$224	–	3395
2026 Q1	$224	Buy	+9	New	+$233	﹤0.01%	4545
2025 Q4	–	Sell	-9	Closed	-$145	–	3027
2025 Q3	$145	Buy	+9	New	+$146	﹤0.01%	4274
2021 Q4	–	Sell	-10,300	Closed	-$90K	–	1453
2021 Q3	$90K	Buy	10,300 +1,300	+14%	+$11.7K	﹤0.01%	1345
2021 Q2	$95K	Buy	+9,000	New	+$126K	﹤0.01%	1641
2021 Q1	–	Sell	-700	Closed	-$32K	–	2118
2020 Q4	$32K	Hold	700	–	–	﹤0.01%	1905
2020 Q3	$25K	Buy	+700	New	+$21.1K	﹤0.01%	1966

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Advisory Services Network's IMVT Position: Q2 2026 in Review

Advisory Services Network sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 9 shares — an estimated $224 sold.

Advisory Services Network first reported a position in IMVT in Q3 2020 and held it in 6 quarters. The position peaked at $95K in Q2 2021. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Advisory Services Network reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 9 Immunovant shares in Q2 2026, an estimated $224.
Advisory Services Network first reported a position in Immunovant in Q3 2020 and held it in 6 quarters.
Advisory Services Network's Immunovant position peaked at $95K in Q2 2021.
227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.